To address this important question, we next performed functional assays of serial co-cultures with leukemic cells (both CML and AML) and MSCs, in which the functionality of Cxcr2 and Il6R was blocked with neutralizing antibodies. The gene discussed is CXCR2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.